New Current Report Filed with the SEC: 8-K – Cellectar Biosciences, Inc. (0001279704) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC). Details of the current report are:

8-K – Cellectar Biosciences, Inc. (0001279704) (Filer)
Filed: 2015-09-30 AccNo: 0001144204-15-057373 Size: 706 KB

Item 1.01: Entry into a Material Definitive Agreement

Item 3.02: Unregistered Sales of Equity Securities

Item 9.01: Financial Statements and Exhibits
Filing Date: 2015-09-30T13:58:08-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: